Harvard endowment declines on flat returns

In a year of flat investment returns, the endowment declines as distributions support Harvard University operations

Harvard’s endowment was valued at $30.7 billion last June 30, the end of fiscal year 2012—a decline of $1.3 billion (4.1 percent) from the prior year. That result, released September 26 in Harvard Management Company’s (HMC) annual report, reflects an investment return of -0.05 percent on endowment and related assets, following the robust return of 21.4 percent in fiscal 2011. The decline in the endowment’s value reflects the investment return (essentially nil); minus distribution of endowment funds to support University operations and for other purposes (perhaps $1.5 billion; the exact sum will be reported in late October); plus gifts received. Endowment distributions account for about one-third of Harvard’s annual revenues.

Domestic equities yielded a return of 9.65 percent, but international stocks declined sharply, producing an overall return of -6.66 percent for public equities—about one-third of the invested assets. Private equities and absolute-return assets (principally hedge funds)—together, about 30 percent of assets—yielded slightly positive returns. Fixed-income holdings (about 10 percent of the total) yielded 7.95 percent. Real assets were mixed, with strong gains in real estate, positive returns in natural resources (timber- and farmland), and significant losses in the commodities portfolio.

Peer institutions’ results demonstrated the important interplay of endowment investment returns, spending, and gifts from capital campaigns. At Yale, a 4.7 percent investment return for fiscal 2012 nearly offset distributions of about $1 billion, so the endowment declined only marginally during the year, from $19.4 billion to $19.3 billion. Stanford’s investments earned only 1 percent, but the endowment rose 3.2 percent in value, to $17 billion, as a surge of campaign gifts apparently more than offset nearly $900 million in spending.

HMC president and CEO Jane L. Mendillo cautioned that “at a time of unusual turbulence with significant macroeconomic issues facings regions around the world…future returns may be uncertain,” but expressed confidence in a strategy of focusing on highly diversified investments and “long-term value creation.”

For a detailed report on Harvard’s endowment performance, see https://harvardmag.com/endowment-12.

You might also like

Harvard Alumni Affairs Databases Breached

The University is investigating the cyberattack, which may have compromised the personal information of alumni, donors, students, faculty, and staff.

Harvard Law School Releases Digital Archive of Nuremberg Trials

Thousands of documents chronicle the Nazi regime and the legal effort to exact justice.

Summers Takes Leave Amid Harvard Probe

Previously undisclosed Epstein links to Harvard affiliates leads to a University review.

Most popular

What Trump Means for John Roberts’s Legacy

Executive power is on the docket at the Supreme Court.

The Life of a Harvard Spy

Richard Skeffington Welch’s illustrious—and clandestine—career in the CIA

Explore More From Current Issue

Aerial view of a landscaped area with trees and seating, surrounded by buildings and parking.

Landscape Architect Julie Bargmann Transforming Forgotten Urban Sites

Julie Bargmann and her D.I.R.T. Studio give new life to abandoned mines, car plants, and more.

A vibrant bar scene with tropical decor, featuring patrons sitting on high stools.

Best Bars for Seasonal Drinks and Snacks in Greater Boston

Gathering spots that warm and delight us  

Professor David Liu smiles while sitting at a desk with colorful lanterns and a figurine in the background.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.